nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—Limb paresis—Hydrochlorothiazide—nephrolithiasis	0.127	0.154	CcSEcCtD
Sertraline—Monoparesis—Hydrochlorothiazide—nephrolithiasis	0.106	0.128	CcSEcCtD
Sertraline—Anxiety disorder—Hydrochlorothiazide—nephrolithiasis	0.0495	0.0598	CcSEcCtD
Sertraline—Maprotiline—CHRM3—nephrolithiasis	0.0243	1	CrCbGaD
Sertraline—Arrhythmia supraventricular—Hydrochlorothiazide—nephrolithiasis	0.0198	0.0239	CcSEcCtD
Sertraline—CYP2C19—urine—nephrolithiasis	0.0176	0.122	CbGeAlD
Sertraline—CYP1A2—urine—nephrolithiasis	0.0144	0.0995	CbGeAlD
Sertraline—Sexual dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0165	CcSEcCtD
Sertraline—CYP2C9—urine—nephrolithiasis	0.0136	0.0944	CbGeAlD
Sertraline—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0138	CcSEcCtD
Sertraline—CYP3A4—urine—nephrolithiasis	0.0104	0.072	CbGeAlD
Sertraline—CYP2D6—urine—nephrolithiasis	0.0102	0.0709	CbGeAlD
Sertraline—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00826	0.00998	CcSEcCtD
Sertraline—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0081	0.00978	CcSEcCtD
Sertraline—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.00785	0.00948	CcSEcCtD
Sertraline—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0078	0.00942	CcSEcCtD
Sertraline—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00766	0.00925	CcSEcCtD
Sertraline—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00719	0.00869	CcSEcCtD
Sertraline—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.007	0.00846	CcSEcCtD
Sertraline—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00693	0.00837	CcSEcCtD
Sertraline—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00639	0.00772	CcSEcCtD
Sertraline—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00633	0.00765	CcSEcCtD
Sertraline—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00633	0.00765	CcSEcCtD
Sertraline—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00627	0.00758	CcSEcCtD
Sertraline—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00622	0.00751	CcSEcCtD
Sertraline—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.006	0.00724	CcSEcCtD
Sertraline—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00595	0.00718	CcSEcCtD
Sertraline—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00592	0.00715	CcSEcCtD
Sertraline—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00589	0.00712	CcSEcCtD
Sertraline—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00584	0.00706	CcSEcCtD
Sertraline—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00577	0.00697	CcSEcCtD
Sertraline—SIGMAR1—nephron tubule—nephrolithiasis	0.00567	0.0393	CbGeAlD
Sertraline—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00558	0.00674	CcSEcCtD
Sertraline—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00556	0.00672	CcSEcCtD
Sertraline—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00552	0.00666	CcSEcCtD
Sertraline—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00547	0.00661	CcSEcCtD
Sertraline—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00547	0.00661	CcSEcCtD
Sertraline—MAOB—nephron tubule—nephrolithiasis	0.00543	0.0376	CbGeAlD
Sertraline—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00537	0.00648	CcSEcCtD
Sertraline—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00527	0.00636	CcSEcCtD
Sertraline—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00523	0.00632	CcSEcCtD
Sertraline—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.0051	0.00616	CcSEcCtD
Sertraline—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00508	0.00614	CcSEcCtD
Sertraline—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00503	0.00607	CcSEcCtD
Sertraline—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00501	0.00605	CcSEcCtD
Sertraline—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00501	0.00605	CcSEcCtD
Sertraline—MAOB—renal system—nephrolithiasis	0.00493	0.0342	CbGeAlD
Sertraline—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00492	0.00594	CcSEcCtD
Sertraline—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00491	0.00592	CcSEcCtD
Sertraline—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00491	0.00592	CcSEcCtD
Sertraline—SIGMAR1—cortex of kidney—nephrolithiasis	0.00485	0.0336	CbGeAlD
Sertraline—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00484	0.00584	CcSEcCtD
Sertraline—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00481	0.00581	CcSEcCtD
Sertraline—MAOB—kidney—nephrolithiasis	0.00477	0.0331	CbGeAlD
Sertraline—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00471	0.00569	CcSEcCtD
Sertraline—MAOB—cortex of kidney—nephrolithiasis	0.00465	0.0322	CbGeAlD
Sertraline—MAOA—nephron tubule—nephrolithiasis	0.00463	0.0321	CbGeAlD
Sertraline—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00449	0.00543	CcSEcCtD
Sertraline—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00447	0.0054	CcSEcCtD
Sertraline—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00444	0.00536	CcSEcCtD
Sertraline—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00443	0.00535	CcSEcCtD
Sertraline—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00439	0.0053	CcSEcCtD
Sertraline—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00437	0.00528	CcSEcCtD
Sertraline—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00434	0.00524	CcSEcCtD
Sertraline—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00425	0.00513	CcSEcCtD
Sertraline—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00422	0.0051	CcSEcCtD
Sertraline—MAOA—renal system—nephrolithiasis	0.00421	0.0292	CbGeAlD
Sertraline—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0042	0.00507	CcSEcCtD
Sertraline—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0042	0.00507	CcSEcCtD
Sertraline—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00418	0.00505	CcSEcCtD
Sertraline—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00417	0.00503	CcSEcCtD
Sertraline—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00411	0.00496	CcSEcCtD
Sertraline—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00409	0.00494	CcSEcCtD
Sertraline—MAOA—kidney—nephrolithiasis	0.00407	0.0282	CbGeAlD
Sertraline—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00404	0.00488	CcSEcCtD
Sertraline—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00402	0.00486	CcSEcCtD
Sertraline—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.004	0.00483	CcSEcCtD
Sertraline—MAOA—cortex of kidney—nephrolithiasis	0.00396	0.0275	CbGeAlD
Sertraline—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00473	CcSEcCtD
Sertraline—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00386	0.00466	CcSEcCtD
Sertraline—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00385	0.00465	CcSEcCtD
Sertraline—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00383	0.00462	CcSEcCtD
Sertraline—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00382	0.00461	CcSEcCtD
Sertraline—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00379	0.00458	CcSEcCtD
Sertraline—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00371	0.00448	CcSEcCtD
Sertraline—CYP2B6—nephron tubule—nephrolithiasis	0.0037	0.0257	CbGeAlD
Sertraline—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00364	0.00439	CcSEcCtD
Sertraline—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00359	0.00433	CcSEcCtD
Sertraline—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00357	0.00431	CcSEcCtD
Sertraline—CYP1A2—renal system—nephrolithiasis	0.00351	0.0243	CbGeAlD
Sertraline—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00344	0.00415	CcSEcCtD
Sertraline—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.0034	0.00411	CcSEcCtD
Sertraline—CYP2B6—renal system—nephrolithiasis	0.00337	0.0233	CbGeAlD
Sertraline—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00335	0.00405	CcSEcCtD
Sertraline—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.0033	0.00399	CcSEcCtD
Sertraline—Tension—Hydrochlorothiazide—nephrolithiasis	0.00329	0.00397	CcSEcCtD
Sertraline—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00328	0.00396	CcSEcCtD
Sertraline—CYP2B6—kidney—nephrolithiasis	0.00326	0.0226	CbGeAlD
Sertraline—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00325	0.00393	CcSEcCtD
Sertraline—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00324	0.00391	CcSEcCtD
Sertraline—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00322	0.00389	CcSEcCtD
Sertraline—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00314	0.00379	CcSEcCtD
Sertraline—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00311	0.00375	CcSEcCtD
Sertraline—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.0031	0.00374	CcSEcCtD
Sertraline—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00308	0.00372	CcSEcCtD
Sertraline—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00306	0.0037	CcSEcCtD
Sertraline—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00302	0.00365	CcSEcCtD
Sertraline—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00301	0.00363	CcSEcCtD
Sertraline—Syncope—Hydrochlorothiazide—nephrolithiasis	0.003	0.00363	CcSEcCtD
Sertraline—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.003	0.00362	CcSEcCtD
Sertraline—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00296	0.00357	CcSEcCtD
Sertraline—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00294	0.00356	CcSEcCtD
Sertraline—Cough—Hydrochlorothiazide—nephrolithiasis	0.00292	0.00353	CcSEcCtD
Sertraline—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00285	0.00344	CcSEcCtD
Sertraline—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00285	0.00344	CcSEcCtD
Sertraline—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00285	0.00344	CcSEcCtD
Sertraline—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00284	0.00343	CcSEcCtD
Sertraline—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00282	0.0034	CcSEcCtD
Sertraline—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00279	0.00337	CcSEcCtD
Sertraline—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00276	0.00333	CcSEcCtD
Sertraline—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00273	0.0033	CcSEcCtD
Sertraline—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00273	0.0033	CcSEcCtD
Sertraline—Shock—Hydrochlorothiazide—nephrolithiasis	0.00269	0.00325	CcSEcCtD
Sertraline—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00268	0.00323	CcSEcCtD
Sertraline—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00267	0.00322	CcSEcCtD
Sertraline—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00264	0.00319	CcSEcCtD
Sertraline—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00261	0.00315	CcSEcCtD
Sertraline—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00255	0.00308	CcSEcCtD
Sertraline—CYP3A4—renal system—nephrolithiasis	0.00254	0.0176	CbGeAlD
Sertraline—CYP2D6—renal system—nephrolithiasis	0.0025	0.0173	CbGeAlD
Sertraline—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00249	0.00301	CcSEcCtD
Sertraline—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00247	0.00299	CcSEcCtD
Sertraline—CYP3A4—kidney—nephrolithiasis	0.00246	0.017	CbGeAlD
Sertraline—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00296	CcSEcCtD
Sertraline—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00244	0.00294	CcSEcCtD
Sertraline—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00243	0.00294	CcSEcCtD
Sertraline—CYP2D6—kidney—nephrolithiasis	0.00242	0.0168	CbGeAlD
Sertraline—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00241	0.00291	CcSEcCtD
Sertraline—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00238	0.00287	CcSEcCtD
Sertraline—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00236	0.00285	CcSEcCtD
Sertraline—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00234	0.00282	CcSEcCtD
Sertraline—Pain—Hydrochlorothiazide—nephrolithiasis	0.00234	0.00282	CcSEcCtD
Sertraline—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00225	0.00272	CcSEcCtD
Sertraline—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00224	0.0027	CcSEcCtD
Sertraline—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00217	0.00262	CcSEcCtD
Sertraline—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00216	0.00261	CcSEcCtD
Sertraline—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00216	0.00261	CcSEcCtD
Sertraline—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00201	0.00243	CcSEcCtD
Sertraline—ABCB1—nephron tubule—nephrolithiasis	0.00198	0.0137	CbGeAlD
Sertraline—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00196	0.00237	CcSEcCtD
Sertraline—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00193	0.00234	CcSEcCtD
Sertraline—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00187	0.00226	CcSEcCtD
Sertraline—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00181	0.00218	CcSEcCtD
Sertraline—ABCB1—renal system—nephrolithiasis	0.0018	0.0125	CbGeAlD
Sertraline—ABCB1—kidney—nephrolithiasis	0.00174	0.0121	CbGeAlD
Sertraline—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00174	0.0021	CcSEcCtD
Sertraline—Rash—Hydrochlorothiazide—nephrolithiasis	0.00172	0.00208	CcSEcCtD
Sertraline—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00172	0.00208	CcSEcCtD
Sertraline—Headache—Hydrochlorothiazide—nephrolithiasis	0.00171	0.00207	CcSEcCtD
Sertraline—ABCB1—cortex of kidney—nephrolithiasis	0.00169	0.0117	CbGeAlD
Sertraline—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00162	0.00196	CcSEcCtD
Sertraline—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.000126	0.0372	CbGpPWpGaD
Sertraline—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.000117	0.0346	CbGpPWpGaD
Sertraline—MAOB—Biological oxidations—SLC26A1—nephrolithiasis	0.000113	0.0332	CbGpPWpGaD
Sertraline—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.000112	0.0329	CbGpPWpGaD
Sertraline—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.000104	0.0306	CbGpPWpGaD
Sertraline—SLC6A4—NRF2 pathway—SLC2A9—nephrolithiasis	9.83e-05	0.029	CbGpPWpGaD
Sertraline—SLC6A2—NRF2 pathway—SLC2A9—nephrolithiasis	8.46e-05	0.0249	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	8.27e-05	0.0244	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	7.57e-05	0.0223	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	7.57e-05	0.0223	CbGpPWpGaD
Sertraline—SLC6A3—NRF2 pathway—SLC2A9—nephrolithiasis	7.49e-05	0.0221	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	7.33e-05	0.0216	CbGpPWpGaD
Sertraline—MAOA—Biological oxidations—SLC26A1—nephrolithiasis	7.07e-05	0.0208	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	6.7e-05	0.0197	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	6.7e-05	0.0197	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	5.73e-05	0.0169	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	5.73e-05	0.0169	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	5.33e-05	0.0157	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	5.33e-05	0.0157	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	5.08e-05	0.015	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	5.08e-05	0.015	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	4.75e-05	0.014	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	4.72e-05	0.0139	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	4.72e-05	0.0139	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	4.72e-05	0.0139	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	4.72e-05	0.0139	CbGpPWpGaD
Sertraline—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	4.46e-05	0.0131	CbGpPWpGaD
Sertraline—CYP2B6—Biological oxidations—SLC26A1—nephrolithiasis	4.43e-05	0.013	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	4.21e-05	0.0124	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	4.2e-05	0.0124	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	4.18e-05	0.0123	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	4.18e-05	0.0123	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	3.84e-05	0.0113	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	3.84e-05	0.0113	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	3.72e-05	0.011	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	3.41e-05	0.01	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	3.41e-05	0.01	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	3.35e-05	0.00986	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	3.08e-05	0.00907	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	3.05e-05	0.00899	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	2.91e-05	0.00858	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	2.91e-05	0.00858	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	2.71e-05	0.00798	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	2.71e-05	0.00798	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	2.61e-05	0.00768	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	2.58e-05	0.0076	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	2.58e-05	0.0076	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GRHPR—nephrolithiasis	2.54e-05	0.00749	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	2.41e-05	0.00711	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	2.41e-05	0.00711	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	2.4e-05	0.00707	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	2.4e-05	0.00707	CbGpPWpGaD
Sertraline—MAOB—Metabolism—AGXT—nephrolithiasis	2.27e-05	0.00668	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	2.14e-05	0.0063	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	2.14e-05	0.0063	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	2.08e-05	0.00612	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	2.08e-05	0.00612	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	2.01e-05	0.00593	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	1.93e-05	0.00568	CbGpPWpGaD
Sertraline—MAOB—Metabolism—APRT—nephrolithiasis	1.93e-05	0.00568	CbGpPWpGaD
Sertraline—MAOB—Metabolism—SLC26A1—nephrolithiasis	1.93e-05	0.00568	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	1.85e-05	0.00545	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	1.71e-05	0.00504	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	1.69e-05	0.00499	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	1.69e-05	0.00499	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GRHPR—nephrolithiasis	1.6e-05	0.0047	CbGpPWpGaD
Sertraline—MAOA—Metabolism—AGXT—nephrolithiasis	1.42e-05	0.00419	CbGpPWpGaD
Sertraline—MAOB—Metabolism—AQP1—nephrolithiasis	1.37e-05	0.00404	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	1.28e-05	0.00378	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	1.28e-05	0.00378	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CHRM3—nephrolithiasis	1.24e-05	0.00366	CbGpPWpGaD
Sertraline—MAOA—Metabolism—SLC26A1—nephrolithiasis	1.21e-05	0.00356	CbGpPWpGaD
Sertraline—MAOA—Metabolism—APRT—nephrolithiasis	1.21e-05	0.00356	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	1.19e-05	0.00351	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	1.19e-05	0.00351	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	1.06e-05	0.00313	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	1.06e-05	0.00313	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GRHPR—nephrolithiasis	9.99e-06	0.00294	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—AGXT—nephrolithiasis	8.91e-06	0.00262	CbGpPWpGaD
Sertraline—MAOA—Metabolism—AQP1—nephrolithiasis	8.62e-06	0.00254	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	8.5e-06	0.0025	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CHRM3—nephrolithiasis	7.79e-06	0.0023	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—APRT—nephrolithiasis	7.57e-06	0.00223	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—SLC26A1—nephrolithiasis	7.57e-06	0.00223	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GRHPR—nephrolithiasis	7.55e-06	0.00222	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GRHPR—nephrolithiasis	7.37e-06	0.00217	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GRHPR—nephrolithiasis	6.95e-06	0.00205	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GRHPR—nephrolithiasis	6.89e-06	0.00203	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—AGXT—nephrolithiasis	6.73e-06	0.00198	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—AGXT—nephrolithiasis	6.57e-06	0.00194	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—AGXT—nephrolithiasis	6.19e-06	0.00182	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—AGXT—nephrolithiasis	6.14e-06	0.00181	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GRHPR—nephrolithiasis	5.88e-06	0.00173	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	5.72e-06	0.00169	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—APRT—nephrolithiasis	5.72e-06	0.00169	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—APRT—nephrolithiasis	5.59e-06	0.00165	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—SLC26A1—nephrolithiasis	5.59e-06	0.00165	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—AQP1—nephrolithiasis	5.4e-06	0.00159	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	5.26e-06	0.00155	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—APRT—nephrolithiasis	5.26e-06	0.00155	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—AGXT—nephrolithiasis	5.24e-06	0.00154	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	5.22e-06	0.00154	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—APRT—nephrolithiasis	5.22e-06	0.00154	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CHRM3—nephrolithiasis	4.88e-06	0.00144	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GRHPR—nephrolithiasis	4.54e-06	0.00134	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—APRT—nephrolithiasis	4.46e-06	0.00131	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	4.46e-06	0.00131	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—AQP1—nephrolithiasis	4.08e-06	0.0012	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—AGXT—nephrolithiasis	4.05e-06	0.00119	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—AQP1—nephrolithiasis	3.98e-06	0.00117	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—AQP1—nephrolithiasis	3.75e-06	0.0011	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—AQP1—nephrolithiasis	3.72e-06	0.0011	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CHRM3—nephrolithiasis	3.69e-06	0.00109	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CHRM3—nephrolithiasis	3.6e-06	0.00106	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—APRT—nephrolithiasis	3.44e-06	0.00101	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	3.44e-06	0.00101	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CHRM3—nephrolithiasis	3.39e-06	0.000999	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CHRM3—nephrolithiasis	3.36e-06	0.000991	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—AQP1—nephrolithiasis	3.18e-06	0.000936	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CHRM3—nephrolithiasis	2.87e-06	0.000846	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—AQP1—nephrolithiasis	2.45e-06	0.000722	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CHRM3—nephrolithiasis	2.22e-06	0.000653	CbGpPWpGaD
